Cambridge develops early lung cancer urine test
Analysis based on 7 articles · First reported May 25, 2026 · Last updated May 27, 2026
This medical breakthrough could significantly improve early lung cancer diagnosis, potentially leading to better patient outcomes and reduced healthcare costs for the United Kingdom — National Health Service>>>. Companies involved in diagnostic technologies and cancer treatment may see increased investment and demand for related services.
Scientists at the University of Cambridge, funded by Cancer Research UK>>>, have developed a groundbreaking urine test for early lung cancer detection. This test identifies 'zombie' cell proteins, allowing for diagnosis months or even years before symptoms appear. Professor Ljiljana Fruk>>> hopes the test will be rolled out across the United Kingdom — National Health Service>>> within five years. The research, conducted in collaboration with the Royal Papworth Hospital, has been published in List of Nature Research journals. This innovation could revolutionize lung cancer treatment by enabling earlier intervention, significantly improving survival rates, as highlighted by Professor Daniel Muñoz-Espín>>> and Professor Robert Rintoul>>>.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard